3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
7
Sarcoma, Ewing
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Osteosarcoma
3
Lymphoma, Large B-Cell, Diffuse
3
Sarcoma, Clear Cell
2
Rhabdomyosarcoma
2
Recurrence
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neurofibrosarcoma
2
Nerve Sheath Neoplasms
2
Lymphoma
2
Liposarcoma
2
Hodgkin Disease
2
Histiocytoma, Angiomatoid Fibrous
2
Granuloma, Plasma Cell
2
Fibrosarcoma
2
Dermatofibrosarcoma
2
Chondrosarcoma, Extraskeletal Myxoid
2
Wilms Tumor
1
Vascular Neoplasms
1
Teratoma
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Pleuropulmonary blastoma
1
Perivascular Epithelioid Cell Neoplasms
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms, Adipose Tissue
1
Interventions
venetoclax
7
ibrutinib
7
Rituximab
6
Mycophenolic Acid
5
Cyclophosphamide
5
fludarabine phosphate
4
Whole-Body Irradiation
4
Sirolimus
4
zanubrutinib
3
pirtobrutinib
3
Peripheral Blood Stem Cell Transplantation
3
Dexamethasone
3
Cyclosporine
3
carfilzomib
2
acalabrutinib
2
Tacrolimus
2
Melphalan
2
Cyclosporins
2
Calcium Dobesilate
2
Busulfan
2
Bendamustine Hydrochloride
2
talquetamab
1
pembrolizumab
1
loncastuximab tesirine
1
ixazomib
1
fludarabine
1
Transplantation
1
Specimen Handling
1
Rifaximin
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Waldenstrom Macroglobulinemia
×
Ifosfamide
×
90 days
×
Clear all
No trials found.